User profiles for Thomas Rose

Thomas Rose

Arzt
Verified email at charite.de
Cited by 805

Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials

…, W Mattheus, G Verween, P De Corte, T Rose… - PloS one, 2009 - journals.plos.org
We describe the small-scale, laboratory-based, production and quality control of a cocktail,
consisting of exclusively lytic bacteriophages, designed for the treatment of Pseudomonas …

A network suitable microwave radiometer for operational monitoring of the cloudy atmosphere

T Rose, S Crewell, U Löhnert, C Simmer - Atmospheric research, 2005 - Elsevier
The implementation of an operational network of microwave radiometers is presently hampered
by the cost and complexity of the available instruments. For this reason, the definition …

[HTML][HTML] Experimental phage therapy of burn wound infection: difficult first steps

T Rose, G Verbeken, D De Vos… - … journal of burns and …, 2014 - ncbi.nlm.nih.gov
Antibiotic resistance has become a major public health problem and the antibiotics pipeline
is running dry. Bacteriophages (phages) may offer an ‘innovative’means of infection …

Use of bacteriophages in the treatment of colistin-only-sensitive Pseudomonas aeruginosa septicaemia in a patient with acute kidney injury—a case report

…, M Merabishvili, P Soentjens, KW Pang, T Rose… - Critical Care, 2017 - Springer
In June 2016, a 61-year-old man was hospitalised for Enterobacter cloacae peritonitis and
severe abdominal sepsis with disseminated intravascular coagulation, secondary to a …

In vivo activity against HIV and favorable toxicity profile of 2′, 3′-dideoxyinosine

R Yarchoan, H Mitsuya, RV Thomas, JM Pluda… - Science, 1989 - science.org
The purine analog 2′,3′-dideoxyinosine (ddI), which has anti-retroviral activity in vitro was
administered for up to 42 weeks to 26 patients with acquired immunodeficiency syndrome (…

Plasma and cerebrospinal fluid pharmacokinetics of 3′‐azido‐3′‐deoxythymidine: a novel pyrimidine analog with potential application for the treatment of patients …

…, JM Collins, R Yarchoan, R Thomas… - Clinical …, 1987 - Wiley Online Library
We investigated the clinical pharmacokinetics of azidothymidine (N 3 TdR) as part of a
phase I/II trial in the treatment of acquired immunodeficiency syndrome and related diseases. …

Evaluation of cisplatin combined with piroxicam for the treatment of oral malignant melanoma and oral squamous cell carcinoma in dogs

…, DL Schlittler, AJ Mutsaers, RM Thomas… - Journal of the …, 2004 - Am Vet Med Assoc
Objective —To determine the maximum tolerated dose (MTD) of cisplatin administered with
piroxicam, the antitumor activity and toxicity of cisplatin combined with piroxicam in dogs with …

Nonprecious alloys for use in fixed prosthodontics: a literature review

JR Kelly, TC Rose - The Journal of prosthetic dentistry, 1983 - Elsevier
The physical properties of nonprecious alloys can differ significantly from those of alloys
containing a high percent of gold. Relationships among constituents, physical properties, and …

IFNα and its response proteins, IP-10 and SIGLEC-1, are biomarkers of disease activity in systemic lupus erythematosus

T Rose, A Grützkau, H Hirseland, D Huscher… - Annals of the …, 2013 - ard.bmj.com
Objectives To evaluate and compare the clinical efficacy of three biomarkers for interferon (IFN)
activity (measured directly and indirectly) and six traditional biomarkers in indicating …

Expert opinion on three phage therapy related topics: bacterial phage resistance, phage training and prophages in bacterial production strains

…, I Mašlaňová, M Merabishvili, R Pantucek, T Rose… - Viruses, 2018 - mdpi.com
Phage therapy is increasingly put forward as a “new” potential tool in the fight against
antibiotic resistant infections. During the “Centennial Celebration of Bacteriophage Research” …